1/14 .,6$h5h1%√∏/*√∏6√∏ 
%(√π(5√∏ 7,%%√∏ √úR√úN√úN ADI 
LAFLEKS 1/3 LAUDEKS %3.33 DEKSTROZ - % 0.3 SODYUM KLOR√úR dg=(/7√∏6√∏ 
.$/√∏7$7√∏)9(.$17√∏7$7√∏)%√∏/(√π√∏0 
Her bir litre √ß√∂zelti: 
Etkin maddeler: 
Dekstroz monohidrat .‚Ä¶‚Ä¶‚Ä¶‚Ä¶‚Ä¶‚Ä¶‚Ä¶..33,3 g /33,3 mg/ml) 
Sodyum Klor√ºr ‚Ä¶‚Ä¶‚Ä¶‚Ä¶‚Ä¶‚Ä¶‚Ä¶‚Ä¶‚Ä¶‚Ä¶3 g (3 mg/ml) 
d|]HOWLQLQL\RQNRQVDQWUDV\RQODU√ï 
-Sodyum: 51 mEq/L 
-Klor√ºr: 51 mEq/L 
<DUG√ïPF√ïPDGGHOHU 
<DUG√ïPF√ïPDGGHOHULoLQ¬∂HEDN√ïQ√ï] 
)$50$6g7√∏.)250 
Enjeksiyonluk √ß√∂zelti. 
Renksiz, berrak ve partik√ºl i√ßermeyen √ß√∂zelti 
./√∏1√∏.g=(//√∏./(5 
4.1 Terap√∂tik endikasyonlar 
-7HUOHPHNXVPDYHPLGHDVSLUDV\RQXJLELQHGHQOHUOHNORU¬ÅUND\E√ïQ√ïQVRG\XPND\E√ïQDH √∫LW 
\DGDGDKDID]ODROGX√∑XGXUXPODU 
- Kan transf√ºzyonu ile birlikte D\U√ïFDV√ïY√ïYHULOPHNLVWHQHQKDVWDODU 
-$PHOL\DW|QFHVLYHVRQUDV√ïEDN√ïP√ïQGDHNVWUDVHO¬ÅOHUV√ïY√ïND\√ïSODU √ïQ√ïQNDU√∫√ïODQDUDNE|EUHN 
L√∫OHYOHULQLQED√∫ODW√ïOPDV√ïQGDLONKLGUDV\RQo|]HOWLVLRODUDN 
3R]RORMLYHX\JXODPD√∫HNOL 
3R]RORML8\JXODPDV√ïNO√ï√∑√ïYH suresi 
8\JXODQDFDNGR]YHLQI¬Å]\RQK√ï]√ïKDVWDQ√ïQ\D√∫√ïQDD√∑√ïUO√ï√∑√ïQDNOLQLNYHEL \RORMLNGXUXPXQD 
(asit- ED]GHQJHVLQHYHELUOLNWHX\JXODQDQWHGDYL\HJ|UHKHNLPLWDUDI√ïQGDQD\DUO DQ√ïU 
*HQHORODUDNGRNWRUWDUDI√ïQGDQED√∫NDW¬ÅUO¬Å|QHULOPHGL\VHHUL√∫NLQ DG| OHVDQYH \D√∫O√ïODUGD 
saatte 500 - 3000 ml, bebek ve √ßocuklarda ise 24 saatte 20-100 ml/kg dozunda √∂nerilir. 2/14 8\JXODPD V√ïNO√ï√∑√ï KDVWDQ√ïQ NOLQLN GXUXPXQD J|UH KHNLP WDUDI√ïQGDQ D\DUOD Q√ïU (UL√∫NLQ YH 
\D√∫O√ïODUGDJHQHOOLNOHVDDWWHPONJSHGL\DWULNYDNDOD rda saatte ortalama 5 ml/kg inf√ºzyon 
K√ï]√ï |QHULOLU EHEHNOHUGH VDDWWH  -8 ml/kg, 1-  \D√∫ DUDV√ï oRFXNODUGD VDDWWH  -6 ml/kg ve 6 
\D√∫√ïQGDQE¬Å\¬ÅNoRFXNODUODHUJHQOHUGHVDDWWH -4 ml/kg). 
+LSHUJOLVHPLJHOL√∫LPLQL|QOHPHNLoLQLQI¬Å]\RQK√ï]√ïKDVWDQ√ïQJOXNR] oksidasyon kapasitesini 
D√∫PDPDO√ïG√ïU%XQHGHQOHPDNVLPXPJOXNR]X\JXODPDK√ï]√ï -PJNJVDDWROPDO√ïG√ïU 
8\JXODPD√∫HNOL 
8\JXODPDVWHULOVHWOHUOHLQWUDYHQ|]\ROGDQ\DS√ïO√ïU 
Hastalar LAFLEKS 1/3 LAUDEKS%3.33 DEKSTROZ - % 0.3 SODYUM KLO R√úR 
dg=(/7√∏6√∏ uygul DPDV√ïV√ïUDV√ïQGDLGUDUo√ïN√ï√∫√ïYHVHUXPVRG\XPYHHOHNWUROLWNRQVDQW UDV\RQODU√ï 
Do√ïV√ïQGDQGLNNDWOLELU√∫HNLOGHWDNLSHGLOPHOLGLU .
8\JXODPD\ODLOJLOLD\U√ïQW√ïODULoLQD\U√ïFDE|O¬ÅP¬∂\DEDN√ïQ√ï] 
g]HOSRS¬ÅODV\RQODUDLOL√∫NLQHNELOJLOHU 
%|EUHN.DUDFL√∑HU\HWPH]OL√∑L 
%XSRS¬ÅODV\RQD|]HOJHUoHNOH√∫WLULOHQELUoDO√ï√∫PDEXOXQPDG√ï√∑√ïQGDQEXKDV WDJUXEXLoLQ|]HOELU 
GR]DM|QHULVLEXOXQPDPDNWDG√ïU 
Pediyatrik pop√ºlasyon: 
8\JXODQDFDNGR]YHLQI¬Å]\RQK√ï]√ïHUL√∫NLQOHUGHNLJLELKDVWDQ√ïQD√∑√ïUO√ï√∑ √ïQD klinik ve biyolojik 
durXPXQDYHELUOLNWHX\JXODQDQWHGDYL\HJ|UHKHNLPLWDUDI√ïQGDQD\DUODQ√ïU 
Bu pop√ºlasyonda genel olarak 24 saatte 20-100 ml/kg dozunda √∂nerilir  ve bu doz v√ºcut 
D√∑√ïUO√ï√∑√ïQDJ|UHD√∫D√∑√ïGDNL√∫HNLOGHD\DUODQ√ïU 
0-10 kg  : 100ml/kg/g√ºn 
10-20 kg: 1000 ml + 10 kg √ºzeri her kilo i√ßin 50 ml/g√ºn 
> 20 kg: 1500 ml + 20 kg √ºzeri her kilo i√ßin 20 ml/g√ºn 
Geriyatrik pop√ºlasyon: 
8\JXODQDFDNGR]YHLQI¬Å]\RQK√ï]√ïHUL√∫NLQOHUGHNLJLELKDVWDQ√ïQD√∑√ïUO√ï√∑ √ïQDNOLQLNYHEL\RORMLN 
durumuna ve birlikte uygulanan tedaviye g√∂re hekim WDUDI√ïQGDQD\DUODQ√ïU 
4.3. Kontrendikasyonlar 
d|]HOWL VRG\XP \D GD NORU¬ÅU X\JXODPDV√ïQ√ïQ NOLQLN RODUDN ]DUDUO√ï ROGX√∑ X √∫X GXUXPODUGD 
kontrendikedir: 
- Ekstrasel√ºler hiperhidrasyon veya hipervolemi 
-6√ïY√ïYHVRG\XPUHWDQVL\RQX\D\J√ïQ|GHP 
- Ciddi b√∂brek yetersizli √∑LROLJ¬ÅULYH\DDQ¬ÅULOL 
-.RPSDQVHROPD\DQNDOS\HWHUVL]OL√∑L 
- Hipernatremi 
- Hiperkloremi 3/14 - Siroz (asit olan) 
-0HWDEROLNVWUHVGXUXPODU√ïJLELJOXNR]LQWROHUDQV√ïGXUXPODU√ï 
- Kompanse olmayan diyabetik koma 
- Hiperozmolar koma 
- Hiperlaktatemi 
-.DQ√∫HNHULQLQD√∫√ïU√ï\¬ÅNVHNROGX√∑XGXUXPODU 
'HNVWUR] LoHUHQ o|]HOWLOHU P√ïV√ïU ND\QDNO√ï ¬ÅU¬ÅQOHUH D√∫√ïU√ï GX\D UO√ïO√ï√∑√ï RODQ KDVWDODUGD 
kontrendikedir. 
g]HONXOODQ√ïPX\DU√ïODU√ïYH|QOHPOHUL 
√∏QWUDYHQ|] o|]HOWLOHULQ X\JXODQPDV√ï VHUXP HOHNWUROLW NRQVDQWUDV\RQXQGD GLO¬ÅV\RQ D√∫√ïU√ï 
KLGUDV\RQ NRQMHVWLI GXUXPODU YH\D SXOPRQHU |GHP ROX√∫WXUDFDN √∫HNLOGH V√ïY√ï YH YH\D VRO¬ÅW 
y√ºklemesine yol a√ßabilir. 
'LO¬ÅV\RQULVNLHOHNWUROLWNRQVDQWUDV\RQX\ODWHUVRUDQW√ïO√ïG√ïU3HUL IHULNYHSXOPRQHU|GHPH\RO 
DoDELOHQNRQMHVWLIGXUXPODU√ïQJHOL√∫PHULVNLLVHo|]HOWLGHNLHOHNW UROLWNRQVDQWUDV\RQX\ODGR√∑UX 
RUDQW√ïO√ïG√ïU 
√á√∂zelti 51mmol/l (51 mEq/l) sodyum (Na +) ve 51 mmol/l (51 mEq/l) klor√ºr (Cl -) i√ßerir; 
2]PRODULWHVL\DNOD√∫√ïNP2VPO¬∂GLU 
%|EUHNL√∫OHYOHUL D]DOP√ï√∫KDVWDODUGDVRG\XPL\RQXLoHUHQo|]H OWLOHULQX\JXODQPDV√ïVRG\XP 
retansiyonuna yol a√ßabilir. Sodyum i√ßeren √ß√∂zeltiler, kortikosteroid veya kortikotropin kullanan 
\DGDGL√∑HUQHGHQOHUOHY¬ÅFXGXQGDWX]UHWDQVL\RQXRODQKDVWDODUGDGLNNDWOLX\JXODQPDO √ïG√ïU 
.RQMHVWLI NDOS \HWPH]OL√∑L H√∫OLN HGHQ \D GD HWPH\HQ UHQDO \D  GD NDUGL\RYDVN¬ÅOHU \HWPH]OLN 
GXUXPXQGD |]HOOLNOH GH KDVWDODU FHUUDKL VRQUDV√ï G|QHPGH \D GD \D√∫O√ï iseler sodyum i√ßeren 
o|]HOWLOHUGLNNDWOHX\JXODQPDO√ïG√ïU 
Sodyum klor√ºr i√ßeren √ß√∂zeltiler hipervolemi, hipertansiyon, pre- HNODPSVL NDOS \HWPH]OL√∑L 
SHULIHULN \D GD SXOPRQHU |GHP E|EUHN L√∫OHY ER]XNOX√∑X ¬ÅULQHU \ROODU√ïQ W√ïNDQ√ïNO √ï√∑√ï 
aldosteronizm ya da sod \XPELULNLPL\OHLOL√∫NLOLKDVWDO√ïNGXUXPODU√ïQGDGLNNDWOLNXOODQ√ïOPDO√ïG√ïU 
3UHPDW¬ÅUH YH\D \HQL GR√∑DQODUGD E|EUHN IRQNVL\RQODU√ï WDP ROX√∫PDG√ï√∑√ï L oLQ D√∫√ïU√ï VRG\XP 
DW√ïODPD] %X QHGHQOH VRG\XP NORU¬ÅU LQI¬Å]\RQODU√ï VHUXP VRG\XP G¬Å]H\OH UL WDNLS HGLOHUHN 
X\JXODQPDO√ïG√ïU 
.DIDWUDYPDV√ïQ√ïWDNLSHGHQLONVDDWLoLQGHJOXNR]LoHUHQo|]HOWL OHULQLQI¬Å]\RQXNRQWUHQGLNH 
ROPDPDNODELUOLNWHNDIDLoLQWDQVL\RQXQDUWW√ï√∑√ïG|QHPOHUGHNDQJOXNR] G¬Å]H\L\DN√ïQGDQWDNLS 
edilmelidir. 
Glukoz i√ßeren √ß√∂zeltilerin inf√ºzyonu hiperglisemiye neden olabilir . Hiperglisemi, iskemik 
EH\LQKDVDU√ïQ√ïDUWW√ïUDFD√∑√ïQGDQYHL\LOH√∫PH\LJHFLNWLUHFH√∑LQGH QDNXWLVNHPLNLQPHGXUXPODU√ïQGD 
JOXNR] LoHUHQ o|]HOWLOHULQ NXOODQ√ïOPDPDV√ï |QHULOLU +LSHUJOLV HPL JHOL√∫LPLQL |QOHPHN LoLQ 
LQI¬Å]\RQ K√ï]√ï KDVWDQ√ïQ JOXNR] RNVLGDV\RQ NDSDVLWHVLQL D√∫PDPDO√ïG√ïU %N]  %|O¬ÅP  
+LSHUJOLVHPLROX√∫PDV√ïGXUXPXQGDLQI¬Å]\RQK√ï]√ïD\DUODQPDO√ïYH\DLQV¬ÅOLQX\JXODQPDO √ïG√ïU 4/14 'L\DEHWYH\DE|EUHN\HWHUVL]OL√∑LRODQKDVWDODUGDJOXNR]WROHUDQV√ïER]XODELO LU%XJLELKDVWDODUD 
X\JXODQG√ï√∑√ïQGD NDQ JOXNR] G¬Å]H\OHUL \DN√ïQGDQ WDNLS HGLOPHOL YH JHUHNLUVH  LQV¬ÅOLQ YHYH\D 
SRWDV\XPX\JXODPDV√ïG¬Å√∫¬ÅQ¬ÅOPHOLGLU 
'HNVWUR] LoHUHQ o|]HOWLOHU GLDEHWHV PHOOLWXV ROGX√∑X ELOLQHQ \D G D VXENOLQLN GL\DEHWOLOHU LOH 
KHUKDQJLELUQHGHQOHNDUERQKLGUDWLQWROHUDQV√ïRODQKDVWDODUDGLNNDWOHX\JXODQPDO √ïG√ïU 
3RWDV\XPLoHUPH\HQo|]HOWLOHULQD√∫√ïU√ïX\JXODQPDV√ïGXUXPX|QHPOLEL UKLSRNDOHPLGXUXPXQD 
yol a√ßabilir. Serum potasyum d√ºzeyleri normal d√ºzeylerinde devam  ettirilmeli ve gerekirse 
tedaviye potasyum eklenmelidir. 
*HUHNWL√∑LGXU umlarda tedaviye esansiyel elektrolitler, mineraller ve vitam inler de eklenmelidir. 
$√∫√ïU√ï QD]RJDVWULN LULJDV\RQ NXVPD LVKDO \D GD JDVWURLQWHVWLQDO  ILVW¬ÅOGHQ GUHQDM JLEL 
HOHNWUROLWOHULQD√∫√ïU√ïND\E√ïGXUXPXQGDHNHOHNWUROLWX\JXODQPDV√ïJHUHNHELOL U 
d|]HOWL\H HNOHQHFHN KHUKDQJL ELU ED√∫ND LODoOD ROX√∫DELOHFHN ELU J HoLPVL]OLN ULVNLQL HQ D]D 
LQGLUPHNLoLQNDU√ï√∫W√ïUPDL√∫OHPLQGHQKHPHQVRQUDX\JXODPDGDQ|QFHYHX \JXODPDV√ïUDV√ïQGD 
EHOLUOLDUDODUODLQI¬Å]\RQX\DS√ïODFDNVRQNDU√ï√∫√ïPGDKHUKDQJLELUEXO DQ√ïNO√ïNYH ya √ß√∂kelme olup 
ROPDG√ï√∑√ïNRQWUROHGLOPHOLGLU 
8\JXODPDNRQWUROO¬ÅELULQI¬Å]\RQSRPSDV√ï\OD\DS√ïODFDNVDWRUEDQ√ïQW¬ÅP¬Å\OH ER√∫DOPDGDQ|QFH 
SRPSDQ√ïQ oDO√ï√∫PDV√ïQ√ïQ GXUPX√∫ ROGX√∑XQD GLNNDW HGLOPHOLGLU DNVL KDOGH KDYD HPEROLVL 
ROX√∫DELOLU 
√á√∂zelti, steril setler a UDF√ïO√ï√∑√ï\ODLQWUDYHQ|]\ROGDQX\JXODQ√ïU√∏QWUDYHQ|]X\JXODPDGDNXOO DQ√ïODQ 
VHWOHULQVDDWWHELUGH√∑L√∫WLULOPHVL|QHULOLU 
<DOQ√ï]FDo|]HOWLEHUUDNVDWRUEDVD√∑ODPYHV√ï]G√ïUP√ï\RUVDNXOODQ√ïQ√ï] 
Laboratuar testleri: 
Uzun s√ºreli parenteral uygulamalarda ya da KDVWDQ√ïQ GXUXPXQXQ JHUHNWLUGL√∑L GXUXPODUGD 
KDVWDGDNL V√ïY√ï GHQJHVL HOHNWUROLW NRQVDQWUDV\RQODU√ï YH DVLW -ED] GHQJHVLQGHNL GH√∑L√∫LNOLNOHUL 
L]OHPHNDPDF√ï\ODNOLQLNGH√∑HUOHQGLUPHYHSHUL\RGLNODERUDWXDUWHV WOHUL\DS√ïOPDO√ïG√ïU1RUPDO 
GH√∑HUOHUGHQ|QHPOLGHUHFHGH VDSPDODUJ|U¬ÅOG¬Å√∑¬ÅQGHGHNVWUR]XQVRG\XPNORU¬ÅUO¬Å o|]HOWLOHUL\D 
GDDOWHUQDWLIo|]HOWLOHUOHEXGH√∑HUOHULQQRUPDOHG|QG¬ÅU¬ÅOPHVLJHUHNLU 
3HGL\DWULNNXOODQ√ïPODLOJLOLX\DU√ïYH|QOHPOHU 
Dekstrozun sodyum klor√ºrl√º √ß√∂zeltilerinin pediyatrik hastalarda etkinl i N YH J¬ÅYHQLUOL√∑L 
XVXO¬ÅQHX\JXQG¬Å]HQOHQPL√∫YHNRQWUROO¬ÅoDO√ï√∫PDODUODJ|VWHULOPL√∫WLU 
Pediyatrik hastalarda dekstroz belirtilen endikasyonlarda etkil i ve g√ºvenilirdir (Bkz. 
(QGLNDV\RQODU/LWHUDW¬ÅUGHSHGL\DWULNKDVWDODUGD|]HOOLNOHGH\HQLGR √∑DQODUGDYHG¬Å√∫¬ÅNGR√∑XP 
D√∑√ïUO√ïNO√ï EHEHNOHUGH KLSHUJOLVHPLKLSRJOLVHPL ULVNLQLQ DUWP√ï√∫ ROPDV√ï QHGHQL\OH LQWUDYHQ|] 
GHNVWUR] GR]XQXQ YH X\JXODPD K√ï]√ïQ√ïQ GLNNDWOH D\DUODQPDV√ï JHUHNWL√∑L ELOGLU LOPHNWHGLU 
3HGL\DWULN KDVWDODUGD |]HOOLNOH GH \HQLGR√∑DQODUGD YH G¬Å√∫¬ÅN GR√∑XP D √∑√ïUO√ïNO√ï EHEHNOHUGH 
GHNVWUR]NXOODQ√ïP√ïQGDVHUXPJOXNR]NRQVDQWUDV\RQODU√ïQ√ïQ\DN√ïQGDQL]OHQPHVLJHUHNL U 
<HQLGR√∑DQODUGD\DGDoRNN¬Åo¬ÅNEHEHNOHUGHV√ïY√ïYHHOHNWUROLWGHQJHVLo RND]PLNWDUODUGDV√ïY√ï 
X\JXODQPDV√ï\ODELOHHWNLOHQHELOPHNWHGLU<HQLGR√∑DQODU√ïQ|]HOOLNOHGH E|EUHNL√∫OHYOHULKHQ¬Å] 5/14 WDP JHOL√∫PHPL√∫ YH V√ïY√ïODUOD VRO¬ÅWOHUL DWPD \HWHQH√∑L N√ïV√ïW O√ï RODQ PLDG√ïQGDQ |QFH GR√∑PX√∫ 
\HQLGR√∑DQODU√ïQWHGDYLVLQGHGLNNDWOLROXQPDO√ïG√ïU6√ïY√ïDO√ïP√ïLGUDUP LNWDU√ïYHVHUXPHOHNWUROLW 
G¬Å]H\OHUL\DN√ïQGDQL]OHQPHOLGLU 
<D√∫O√ïODUGDNXOODQ√ïP√ï\ODLOJLOLX\DU√ïYH|QOHPOHU 
'HNVWUR]XQVRG\XPNORU¬ÅUO¬Åo|]HOWLOHULLOHJHUoHNOH√∫WLULOHQNOLQL NoDO√ï√∫PDODUGD\D√∫O√ïODU√ïQJHQo 
HUL√∫NLQOHUHJ|UHGDKDIDUNO√ï\DQ√ïWYHULSYHUPHGLNOHULQLQEHOLUO HQHELOPHVLQH\HWHFHNNDGDU\D√∫ 
YH¬Å]HULNL√∫L\HUDOPDP√ï√∫W√ïU%LOGLULOHQGL√∑HUNOLQLNGHQH\LPO HUHJ|UH\D√∫O√ïODUODJHQoHUL√∫NLQOHU 
DUDV√ïQGD\DQ√ïWWDIDUNO√ïO√ïNODUEXOXQDPDP√ï√∫W√ïU 
*HQHO RODUDN \D√∫O√ï KDVWDODUGD GR] GLNNDWOH VHoLOPHOLGLU <D√∫O√ïO DUGD NDUDFL√∑HU E|EUHN YH\D 
NDUGL\DNL√∫OHYOHULQD]DOP√ï√∫RODELOHFH√∑LELUOLNWHED√∫NDLODoODU √ïQGDNXOODQ√ïODELOHFH√∑L\DGDWHGDYL 
HGLOPH\H oDO√ï√∫√ïODQ GXUXPGDQ ED√∫ND KDVWDO√ïNODU√ïQ GD EXOXQDELOHFH√∑L G¬Å√∫¬ÅQ¬ÅO HUHN JHQHOGH 
WHGDYL\HGR]DUDO√ï√∑√ïQ√ïQHQDOW√ïQGDNLGR]ODUODED√∫ODQPDV√ï|QHULOLU 
Bu ila√ßlar b√ºy√ºk oranda b√∂brekler yoluyl D DW√ïOPDNWDG√ïU YH EX QHGHQOH E|EUHN L√∫OHYOHULQLQ 
ER]XOGX√∑XKDVWDODUGDEXLODoODUDNDU√∫√ïWRNVLNUHDNVL\RQULVNLDUWPDNWDG√ïU 
%|EUHNL√∫OHYOHULQGHD]DOPD\D√∫O√ïODUGDJHQoHUL√∫NLQOHUHJ|UH GDKDID]ODRUDQGDJ|U¬ÅOG¬Å√∑¬ÅQGHQ 
\D√∫O√ï KDVWDODUGD GR] VHoLPLQGH GLNNDWOL ROXQPDO√ïG√ïU E|EUHN L√∫OHYOHU LQLQ L]OHQPHVL \DUDUO√ï 
RODELOLU%N]¬≥8\DU√ïODU¬¥E|O¬ÅP¬Å 
'L√∑HUW√ïEEL¬ÅU¬ÅQOHULOHHWNLOH√∫LPOHUYHGL√∑HUHWNLOH√∫LP√∫HNLO OHUL 
Sodyum i√ßeren √ß√∂zeltiler, kortikosteroid ve karbenoksolon alan hastalarda  sodyum ve su 
tutulumuna (√∂dem ve hipertansiyona) neden olabilir. 
Dekstroz i√ßeren √ß√∂zeltiler, yeterli elektrolit i√ßermiyorsa kan tranf√ºzyonu ile birlikte 
X\JXODQPDPDO√ïG√ïUKHPROL]YHHULWURVLWDJORPHUDV\RQXQDVHEHSRODELOLUOHU 
4.6 Gebelik ve laktasyon 
Genel tavsiye 
Gebelik kategorisi: C 
dRFXNGR√∑XUPDSRWDQVL\HOLEXOXQDQNDG√ïQODU'R√∑XPNRQWURO¬Å.RQWUDVHSVL\RQ
LAFLEKS 1/3 LAUDEKS%3.33 DEKSTROZ - % 0.3 SODYUM KLOR√úR dg=(/7√∏6√∏¬∂QLQ 
√ßRFXN GR√∑XUPD SRWDQVL\HOL EXOXQDQ NDG√ïQODUGD NXOODQ√ïP√ïQD JHEHOLN YH GR√∑XP NRQWURO¬ÅQH  
LOL√∫NLQ|]HOELU|QHULEXOXQPDPDNWDG√ïU 6/14 Gebelik d√∂nemi 
+D\YDQODU ¬Å]HULQGH \DS√ïODQ oDO√ï√∫PDODU JHEHOLNYH -YH\D HPEUL\RQDO IHWDO JHOL√∫LP YH -veya 
GR√∑XPYH -YH\DGR√∑XPVRQUDV√ïJHOL√∫LP¬Å]HULQGHNLHWNLOHUEDN√ïP√ïQGDQ\HWHUVL] GLUEN].√ïV√ïP 
5.3). 'HNVWUR]XQ VRG\XP NORU¬ÅUO¬Å o|]HOWLOHUL\OH KD\YDQ ¬ÅUHPH oDO√ï√∫PDODU √ï 
JHUoHNOH√∫WLULOPHPL√∫WLU'HNVWUR]XQVRG\XPNORU¬ÅUO¬Åo|]HOWLOHULQLQ JHEHNDG√ïQODUGDNXOODQ√ïP√ïQD 
LOL√∫NLQ\HWHUOLYHULPHYFXWGH√∑LOGLU√∏QVDQODUD\|QHOLNSRWDQVL\HOUL VNELOLQPHPHNWHGLU 
LAFLEKS 1/3 LAUDEKS%3.33 DEKSTROZ - % 0.3 SODYUM KLOR√úR dg=(/7√∏6√∏¬∂QLQ 
JHEH NDG√ïQODUD X\JXODQG√ï√∑√ïQGD IHWXVWD KDVDUD \D GD ¬ÅUHPH \HWHQ H√∑LQGH ER]XOPD\D \RO Do√ïS 
DoPD\DFD√∑√ï GD ELOLQPHPHNWHGLU /$)/(.6  /$8'(.6  '(.6 752= - % 0.3 
SODYUM KLOR√úR dg=(/7√∏6√∏ gebe k DG√ïQODUGDDQFDNoRNJHUHNOL\VHNXOODQ√ïOPDO√ïG√ïU 
'R√∑XP 
LAFLEKS 1/3 LAUDEKS %3.33 DEKSTROZ - % 0.3 SODYUM KLOR√úR dg=(/7√∏6√∏¬∂QLQ 
WUDYD\YHGR√∑XPH\OHPLV√ïUDV√ïQGDNXOODQ√ïOG√ï√∑√ïQGDGR√∑XPH\OHPLQLQV¬ÅU HVL¬Å]HULQGHNLHWNLOHUL 
IRUVHSVOHGR√∑XP\DGDGL√∑HUJLUL√∫LPOHU¬Å]HULQGHNLHWNLOHULYH\ D\HQLGR√∑DQGD\DS√ïOPDV√ïJHUHNOL 
GL√∑HUJLUL√∫LPOHU¬Å]HULQGHNLHWNLOHUL\OHEHEH√∑LQGDKDVRQUDNLE¬Å\¬ÅP HJHOL√∫PHYHIRQNVL\RQHO 
ROJXQOD√∫PDV√ï¬Å]HULQGHNLHWNLOHULELOLQPHPHNWHGLU 
/LWHUDW¬ÅUGH WUDYD\ YH GR√∑XP H\OHPLQGH GHNVWUR] Y e sodyum klor√ºr i√ßeren √ß√∂zeltilerin 
NXOODQ√ïOG√ï√∑√ïELOGLULOPL√∫WLU$QQHYHIHWXVXQV√ïY√ïGHQJHVLJOXNR]YHHOH NWUROLWNRQVDQWUDV\RQODU√ï 
ile asit- ED] GHQJHVL G¬Å]HQOL RODUDN YH\D KDVWD \D GD IHWXVXQ GXUXPX JHUHNWLUGL √∑L ]DPDQ 
GH√∑HUOHQGLULOPHOLGLU 
Laktasyon d√∂nemi 
%X LODF√ïQ DQQH V¬ÅW¬ÅQH JHoLS JHoPHGL√∑L ELOLQPHPHNWHGLU %LUoRN LOD F√ïQ DQQH V¬ÅW¬ÅQH JHoWL√∑L 
ELOLQGL√∑LQGHQHP]LUPHNWHRODQDQQHOHUGH LAFLEKS 1/3 LAUDEKS %3.33 DEKSTROZ - %
0.3 SODYUM KLOR√úR dg=(/7√∏6√∏ GLNNDWOHNXOODQ√ïOPDO√ïG√ïU 
$UDoYHPDNLQHNXOODQ√ïP√ï √ºzerindeki etkiler 
√∏QI¬Å]\RQ \ROX\OD X\JXODQDQ o|]HOWLOHULQ NXOODQ√ïP√ï V√ïUDV√ïQGD DUDo NXO ODQ√ïP√ï SUDWLN \|QGHQ 
P¬ÅPN¬ÅQ GH√∑LOGLU .XOODQ√ïOG√ïNWDQ VRQUD DUDo YH PDNLQD NXOODQPD ¬Å]HULQGH ELO LQHQ ELU HWNLVL 
yoktur. 
√∏VWHQPH\HQHWNLOHU 
√∏VWHQPH\HQ HWNLOHU o|]HOWLGHNL L\RQODU√ïQ YH GHNVWUR]XQ HNVLNOL√∑L \ D GD ID]ODO√ï√∑√ïQGDQ 
ND\QDNODQDELOLUEXQHGHQOHVRG\XPYHNORU¬ÅUG¬Å]H\OHULQLQ\DN√ïQGDQL]OHQPHVLJHUH NOLGLU 
$\U√ïFDVH\UHOWLOHUHNX\JXODQDQHNLODoODU√ïQGDDGYHUVHWNLOHU H\RODoDELOHFH√∑LNRQXVXQGDX\DQ√ïN 
ROXQPDO√ïG√ïU%|\OHELUGXUXPGDX\JXODQDQHNLODF√ïQ¬ÅU¬ÅQELOJLVLQHEDN√ïOPDO√ïG√ïU 7/14 LAFLEKS 1/3 LAUDEKS %3.33 DEKSTROZ - % 0.3 SODYUM KLOR√úR dg=(/7√∏6√∏ 
NXOODQ√ïP√ïQDED√∑O√ïELOGLULOHQLVWHQPH\HQHWNLOHU√∫XQODUG√ïU%XD GYHUVHWNLOHULQJ|U¬ÅOPHV√ïNO√ï√∑√ï 
L]OH\HQ NULWHUOHU NXOODQ√ïODUDN GH√∑HUOHQGLULOPL√∫WLU dRN \D\J√ïQ  ¬ï \D\J√ïQ ¬ï LOD 
 \D\J√ïQ ROPD\DQ ¬ï LOD  VH\UHN ¬ï LOD  oRN VH\UHN 
(<1/10.000), bilinmiyor (eldeki verilerden hareketle tahmin edilemiyor). 
.DUGL\DNKDVWDO√ïNODU 
√áok ya \J√ïQ .DOS\HWPH]OL√∑LNDOSKDVWDODU√ïQGD 
9DVN¬ÅOHUKDVWDO√ïNODU 
dRN\D\J√ïQ +LSHUKLGUDV\RQ3ROL¬ÅULLOHELUOLNWHYH\DGH√∑LO 
6ROXQXPJ|√∑¬ÅVER]XNOXNODU√ïYHPHGLDVWLQDOKDVWDO√ïNODU 
√áok \D\J√ïQ :A NFL√∑HU|GHPL 
$UD√∫W√ïUPDODU 
dRN\D\J√ïQ :$VHPSWRPDWLNHOHNWUROLWGHQJHVLER]XNOX√∑X 
dRN\D\J√ïQROPD\DQ : Hiponatremi  
&HUUDKLYHW√ïEELSURVHG¬ÅUOHU 
Bilinmiyor : Febril reaksiyonlar; enjeksiyon b√∂lgesinde HQIHNVL\RQORNDOD√∑U√ï\D da 
reaksiyon; ven iritasyonu; enjeksiyon uygulanan b√∂lgeden ED√∫OD\DUDN \D\√ïODQ 
ven√∂z tromboz ve f OHELWJHOL√∫LPLGDPDUG√ï√∫√ïQDV√ï]PDKLSHUYROHPL 
8\JXODPDWHNQL√∑LQHED√∑O√ïJ|U¬ÅOHELOHQDGYHUVHWNLOHU 
6H\UHOWLOHUHN X\JXODQDQ HN LODoODU√ïQ GD DGYHUV HWNLOHUH \RO D oDELOHFH√∑L NRQXVXQGD X\DQ√ïN 
ROXQPDO√ïG√ïU%|\OHELUGXUXPGDX\JXODQDQLODF√ïQ¬ÅU¬ÅQELOJLVLQHEDN√ïOPDO√ïG√ïU 
√∏VWHQPH\HQHWNLOHULQJ|U¬ÅOPHVLGXUXPXQGDLQI¬Å]\RQNHVLOPHOLKDVWDGH√∑ HUOHQGLULOPHOLX\JXQ 
WHUDS|WLN |QOHPOHU DO√ïQPDO√ï YH JHUHNOL J|U¬ÅOG¬Å√∑¬ÅQGH WRUEDG a kalan √ß√∂zelti inceleme i√ßin 
VDNODQPDO√ïG√ïU 
√π¬ÅSKHOLDGYHUVUHDNVL\RQODU√ïQUDSRUODQPDV√ï 
5XKVDWODQG√ïUPD VRQUDV√ï √∫¬ÅSKHOL LODo DGYHUV UHDNVL\RQODU√ïQ√ïQ UDSRUODQP DV√ï E¬Å\¬ÅN |QHP 
WD√∫√ïPDNWDG√ïU 5DSRUODPD \DS√ïOPDV√ï LODF√ïQ \DUDUULVN GHQJHVLQL Q V¬ÅUHNOL RODUDN L]O enmesine 
RODQDNVD√∑ODU6D√∑O√ïNPHVOH√∑LPHQVXSODU√ïQ√ïQKHUKDQJLELU√∫¬ÅSKHOLD GYHUVUHDNVL\RQX7¬ÅUNL\H 
Farmakovijilans Merkezi (T√úFAM)‚Äôa bildirmeleri gerekmektedir 
(www.titck.gov.tr/ e-posta tufam@titck.gov.tr/ Tel: 0 800 314 00 08/ Faks: 0 312 218 35 99). 8/14 'R]D√∫√ïP√ïYHWHGDYLVL 
5HQDOVRG\XPDW√ïO√ïP√ïQ√ïQER]XNROGX√∑XGXUXPODUGDD√∫√ïU√ïNXOODQ√ïP\DGDK√ï] O√ïLQI¬Å]\RQSHULIHULN 
|GHP YH DNFL√∑HU |GHPLQH \RO DoDELOHQ VX YH VRG\XP \¬ÅNOHPHVLQH QHGHQ RO DELOLU %X JLEL 
durumlarda diyaliz gerekebilir. 
7HUDS|WLNGR]ODUGDKLSHUQDWUHPLQDGLUHQJHOL√∫HELOLU+LSHUQDWUHPLQLQHQ|QHPOL HWNLVLV√ïUDV√ïLOH 
VRPQRODQVNRQI¬Å]\RQNRQY¬ÅOVL\RQNRPDVROXQXP\HWHUVL]OL√∑LYH|O¬ÅPLOHVRQXoOD QDELOHQ 
EH\LQ GHKLGUDWDV\RQXGXU 'L√∑HU EHOLUWLOHU VXVX]OXN W¬ÅN¬ÅU¬ÅN YH J|]\D√∫√ïQ√ïQ D] DOPDV√ï DWH√∫ 
WD√∫LNDUGLKLSHUWDQVL\RQED√∫D√∑U√ïV√ïVHUVHPOLNKLVVLKDOVL]OLNLULWDELOL WHYHJ¬ÅoV¬Å]O¬ÅNW¬ÅU 
.ORU¬ÅUWX]ODU√ïQ√ïQD√∫√ïU√ï\¬ÅNOHQPHVLDVLGLIL\HHGLFLHWNLVLLOHELNDUERQDW ND\E√ïQDQHGHQRODELOLU 
Glukoz i√ßer HQ o|]HOWLOHULQ K√ï]O√ï YH\D X]XQ V¬ÅUH X\JXODQPDV√ï KLSHUR]PRODULWH GH KLGUDV\RQ 
KLSHUJOLVHPLKLSHUJOXNR]¬ÅULYHKLSHUJOLVHPL\HED√∑O√ïR]PRWLNGL¬ÅUH]HQHGHQRODEL OLU 
.D]D LOH RODQ D√∫√ïU√ï LQI¬Å]\RQ GXUXPODU√ïQGD WHGDYL VRQODQG√ïU√ïOPDO√ï YH  KDVWD X\JXODQDQ LODF√ïQ 
VHPSWRPYHEHOLUWLOHULQLJ|]OHPHNLoLQWDNLSHGLOPHOLGLU*HUH NWL√∑LGXUXPODUGDLOJLOLVHPSWRP 
YHEHOLUWLOHUHNDU√∫√ïGHVWHNOH\LFLWHGDYL\DS√ïOPDO√ïG√ïU 
)$50$.2/2-√∏.g=(//√∏./(5 
LAFLEKS 1/3 LAUDEKS %3.33 DEKSTROZ - % 0.3 SODYUM KLOR√úR dg=(/7√∏6√∏¬∂QLQ 
farmakod LQDPLNYHIDUPDNRNLQHWLN|]HOOLNOHULLoHUL√∑LQGHEXOXQDQJOXNR]VRG\XPYH NORU¬ÅUH 
ED√∑O√ïG√ïU 
√á√∂zelti her bir litresinde 33.3 g dekstroz monohidrat 51 mEq sodyum ve 51 mEq klor√ºr i√ßerir.
d|]HOWLQLQS+¬∂V√ï -DUDV√ïQGDG√ïU 
5.1 Farmakodinamik √∂zellikler 
Farmakoterap√∂tik grup: (OHNWUROLW GHQJHVLQL HWNLOH\HQ o|]HOWLOHU.DUERQKLGUDWO√ï HOHNWURO LW 
√ß√∂zeltileri 
ATC kodu:                         B05BB02 
6RG\XPJLELL\RQODUVRG\XPSRPSDV√ï1D -K-$73D]JLELoH√∫LWOLWUDQVSRUWPHNDQL]PDODU√ïQ√ï 
NXOODQDUDN K¬ÅFUH ]DU√ïQGDQ JHoHUOHU 6RG\XP Q|URWUDQVPLV\RQ NDUGL\DN HO HNWURIL]\RORML YH 
renal metabolizmada √∂nemli rol oynar. 
.ORU¬ÅU HVDV RODUDN HNVWUDVHO¬ÅOHU ELU DQ\RQGXU √∏QWUDVHO¬ÅOHU NORU¬ÅU N√ïUP√ï]√ï NDQ K¬ÅFUHOHUL YH 
gastrik mukozada y√ºksek konsantrasyonda bulunur. Klor√ºr geri emilimi, sody umun geri 
emilimini takip eder. 
*OXNR]K¬ÅFUHPHWDEROL]PDV√ïQGDDV√ïOHQHUMLND\QD√∑√ïG√ïU%Xo|]HOWLOH UKDVWDQ√ïQNOLQLNGXUXPXQD 
ED√∑O√ï RODUDN GL¬ÅUH]L X\DUDELOLUOHU *OXNR] WDPDPHQ PHWDEROL]H ROD UDN Y¬ÅF ut protein ve azot 
ND\√ïSODU√ïQ√ïD]DOW√ïUJOLNRMHQGHSRODQPDV√ïQ√ïDUWW√ïU√ïU<HWHUOL GR]ODUGDYHULOGL√∑LQGHNHWR]LVLD]DOW√ïU 
veya engeller. 9/14 .DUERQKLGUDWO√ï VRG\XP NORU¬ÅU o|]HOWLOHUL Y¬ÅFXGXQ V√ïY√ï YH HOHNWUROLW  HNVLNOLNOHUL LOH ELUOLNWH 
kalori gereksiniminin bir E|O¬ÅP¬ÅQ¬ÅNDU√∫√ïODPDNDPDF√ï\ODJHOL√∫WLULOPL√∫WLU%Xo|]HOWLOHUWHUOH PH 
NXVPDPLGHDVSLUDV\RQXJLELQHGHQOHUOHNORU¬ÅUND\E√ïQ√ïQVRG\XPDH√∫LW \DGDGDKDID]ODROGX√∑X 
GXUXPODUGD\DUDUO√ïVRQXoYHULUOHU 
$\U√ïFD KDVWDODUD < WLSLQGH LQWUDYHQ|] ELU LQI¬Å]\RQ FLKD]√ï\OD ELU \DQGDQ NDQ GL√∑HU \DQGDQ 
HOHNWUROLWVL]GHNVWUR]o|]HOWLOHULQLQX\JXODQPDV√ïV√ïUDV√ïQGDH ULWURVLWOHUGHSV|GRDJO¬ÅWLQDV\RQODU 
PH\GDQD JHOPHNWHGLU %XQODUKHPROL]OHVRQXoODQPDVDELOHWUDQVI¬Å]\RQ U HDNVL\RQODU√ïQD \RO 
a√ßabilirler. Kan ile sudaki dekstroz o|]HOWLOHUL DUDV√ïQGDNL EX JHoLPVL]OL√∑L RUWDGDQ NDOG√ïUPDN 
LoLQGHNVWUR]LoHUHQo|]HOWLOHUHELUPLNWDUHOHNWUROLWNDW√ïO PDV√ïJHUHNPHNWHGLURUDQ√ïQGD 
VRG\XPNORU¬ÅULoHUHQGHNVWUR]o|]HOWLOHULNDQODELUOLNWHD\Q√ïDQGDYHULOHELOL UOHU 
$PHOL\DW |QFHVL YH VRQUDV√ï G|QHPGH SRWDV\XPOX o|]HOWLOHU YHULOP HGHQ |QFH KDVWDODUGDNL 
E|EUHNL√∫OHYOHULQLQED√∫ODPDV√ïJHUHNPHNWHGLU(NVWUDVHO¬ÅOHUV√ïY√ïND\ √ïSODU√ïQ√ïNDU√∫√ïOD\DUDNE|EUHN 
L√∫OHYOHULQL ED√∫ODWDELOHFHN LON KLGUDV\RQ √ß√∂zeltisi olarak, i√ßinde %0.2 y D GD   RUDQ√ïQGD 
VRG\XPNORU¬ÅURODQGHNVWUR]o|]HOWLOHULE¬Å\¬ÅNELUGH√∑HUWD√∫√ïU 
$PHOL\DWO√ïKDVWDODUGDV√ïY√ïWHGDYLVL 
$PHOL\DWODUGDQ |QFH KDVWDODUGD J|U¬ÅOHELOHQ HQ |QHPOL V√ïY√ï -HOHNWUROLW PHWDEROL]PDV√ï 
NRPSOLNDV\RQXHNVWUDVHO¬ÅOHUV√ïY√ïND\E√ïQDED√∑O√ï dehidratasyondur. Bu durum kusma, diyare, 
mide- EDUVDN GUHQDM√ï W√ïNDQP√ï√∫ EDUVDN E|O¬ÅPOHUL LoLQH V√ïY√ï GROPDV√ï \D GD  WUDYPD\D X√∑UDP√ï√∫ 
GRNXODUGDV√ïY√ïODU√ïQGDPDUG√ï√∫√ïQDV√ï]PDV√ïJLELQHGHQOHUOHROX√∫XU$\U√ï FDEXODQW√ïYHL√∫WDKV√ï]O√ïN 
GXUXPXQGD GD JHQHO RODUDN V√ïY√ï DO√ïP√ï D]DOP√ï√∫W√ïU +DVWDO√ï√∑√ïQ QHGH Q ROGX√∑X NDWDEROL]PD 
UHDNVL\RQODU√ïYHEHVOHQHPHPHGXUXPXoRNGHIDGRNXODUGDQV√ïY√ïYHSRWDV\ XPND\E√ïQD\RODoDU 
%X GXUXP DoO√ïN NDWDEROL]PDV√ï YH NHWR]X LOH GDKD GD √∫LGGHWOHQLU $√∑√ïU  LQWUDVHO¬ÅOHU 
GHKLGUDWDV\RQNDQGROD√∫√ïP√ïQGDNLV√ïY√ïKDFPLQL|\OHVLQHD]DOWDELOLUNL EHOLUJLQELUNDQDPD\D\D 
GDSOD]PDND\E√ïROPDG√ï√∑√ïKDOGHKDVWDODUGDKLSRYROHPLN√∫RNROX√∫DELOLU 
%|\OH KDVWDODU√ïQ HWNLQ ELU SDUHQWHUDO WHGDYL\OH DPHOL\DWD KD]√ïUODQPDODU√ï JHUHNLU %|EUHN 
L√∫OHYOHULQLED√∫ODWDELOPHN LoLQLONRODUDNRUDQ√ïQGDD√∑√ïULQWU DVHO¬ÅOHUND\E√ïRODQKDVWDODUGD 
RUDQ√ïQGDVRG\XPNORU¬ÅULoHUHQGHNVWUR]OXELUKLGUDV\RQo|]HOWLVLGDNL NDLoLQGHYHULOLU 
+DVWD \HWHUL NDGDU LGUDU o√ïNDUPD]VD \D GD VRQGD LOH DO√ïQDQ L GUDU PLNWDU√ï \HWHUOL GH√∑LOV e, 
o|]HOWLQLQX\JXODPDK√ï]√ïG|UWWHELULQGLULOHUHNX\JXODPD\DELUVDDWVRQUDG HYDPHGLOLU%XV¬ÅUH 
VRQXQGD GD \HWHUOL LGUDU \RNVD KDVWDQ√ïQ E|EUHN L√∫OHYOHUL D√∫√ïU√ï GHUHF HGH ER]XOPX√∫ GHPHNWLU 
klinik durum tekrar g√∂zden ge√ßirilmelidir. 
+DVWD LGUDU o√ïNDUPD\D ED√∫ODG√ïNWDQ VRQUD Y¬ÅFXW D√∑√ïUO√ï√∑√ïQD VHUXP H OHNWUROLW G¬Å]H\OHULQH YH 
DQHPQH]H GD\DQ√ïODUDN V√ïY√ï YH HOHNWUROLW ND\√ïSODU√ï KHVDSODQ√ïU ( NVWUDVHO¬ÅOHU ND\√ïSODU√ïQ 
NDU√∫√ïODQPDV√ïQGD PXOWLSO HOHNWUROLW o|]HOWLOHUL NXOODQ√ïO√ïU $√∑√ïU  DVLGR]GD VRG\XP ODNWDW 
bikarbonat \DGDDVHWDWYHULOPHOLGLU+¬ÅFUHLoLSRWDV\XPHNVLNOL√∑LQLNDU √∫√ïODPDNDPDF√ï\ODEX 
V√ïY√ïODUDD\U√ïFDSRWDV\XPNORU¬ÅUDVHWDWYH\DIRVIDWNRQPDO√ïG√ïU 
+DVWDODUGDNL V√ïY√ï YH HOHNWUROLW ND\√ïSODU√ï \HULQH NRQGXNWDQ VRQUD J¬ÅQO¬Å N V√ïY√ï YH HOHNWUROLW 
gereksinimlerinin NDU√∫√ïODQPDV√ï LGDPH HOHNWUROLW o|]HOWLOHUL LOH VD√∑ODQ√ïU %HV OHQPHVL LOHUL 
GHUHFHGH ER]XOPX√∫ KDVWDODUGD KLSHUWRQLN GHNVWUR] o|]HOWLOHUL\OH JHU HNOL HQHUML DPLQR DVLW 
o|]HOWLOHUL\OHSURWHLQVHQWH]LLoLQJHUHNOLDPLQRDVLWOHUYHHOHNWUROLW OHUVD√∑ODQ√ïU 
Ka Q ND\E√ïQD ED√∑O√ï KLSRYROHPLGH NROORLG ND\E√ï GHNVWUDQ \D GD QL√∫DVWD Lo HUHQ o|]HOWLOHU 
DOE¬ÅPLQ\DGDWDPNDQNXOODQ√ïOPDO√ïG√ïU 10/14 3RVWRSHUDWLIG|QHPGHNLSDUHQWHUDOV√ïY√ïJHUHNVLQLPLKDVWDQ√ïQDPHOL\D WWDQ|QFHNLV√ïY√ï -elektrolit 
GHQJHVLQHYH\DS√ïODQDPHOL\DWDJ|UHGH√∑L√∫LU+DVWDDPHOL\DWD L\LKD]√ïUODQP√ï√∫VDGDKD|QFHNL 
E¬ÅW¬ÅQ ND\√ïSODU√ï \HULQH NRQPX√∫WXU $PHOL\DWWDQ VRQUD \DS√ïODFDN V√ïY√ï W HGDYLVL J¬ÅQO¬ÅN V√ïY√ï 
ND\√ïSODU√ï\HULQHNR\PDNYHPLGH -EDUVDNGUHQDM√ïYE\ROODRODQND\√ïSODU√ïNDU√∫√ïODPDNDPDF√ïQ√ï 
g√ºder. Ameliyat VRQUDV√ïG|QHPGHGDLPDELUPLNWDUVXYHWX]UHWDQVL\RQXYDUG√ïU$\U√ïFD \D√∑ODU√ïQ 
YHGRNXODU√ïQNDWDEROL]PDV√ïQDED√∑O√ïRODUDNELUPLNWDUV√ïY√ïVHUEHVWOH√∫PHVLROXU
%XQHGHQOHDPHOL\DWWDQKHPHQVRQUDVWUHVUHDNVL\RQXJHoLQFH\HNDGD UYHULOHQV√ïY√ïKDFPLD] 
olma O√ïG√ïU*HQHORODUDNDPHOL\DWVRQUDV√ïV√ïY√ïWHGDYLVLD√∫D√∑√ïGDNL√∫HNLOGH|]HWO HQHELOLU 
1. .RPSOLNH ROPDP√ï√∫ L\LOH√∫PH G|QHPL 9¬ÅFXW V√ïY√ïODU√ï GHQJHGH EHVOHQPH VL L\L E|EUHN 
L√∫OHYOHUL QRUPDO HOHNWLI HQGLNDV\RQODUGD YH RUWD GHUHFHGH FHUUDKL  WUDYPD\D X√∑UDP√ï√∫ 
hastal DUGD RUWDODPD  OLWUH LGDPH HOHNWUROLW o|]HOWLVL DPHOL\D W VRQUDV√ï LON J¬ÅQGHNL 
JHUHNVLQLPLNDU√∫√ïODU%XQGDQVRQUDD√∑√ï]\ROXQGDQEHVOHQPH\HJHoLOLU 
<XNDU√ïGDNLKDVWDODUODD\Q√ï|]HOOLNOHUHVDKLSDQFDNDPHOL\DW VRQUDV√ïGUHQDM\DGDDVSLUDV\RQ 
uygulanan hastalarda, uzunca bir s√ºre, yerine koyma ve idame tedavisine gerek duyulur. 
%X KDVWDODUGDNL SDUHQWHUDO V√ïY√ï WHGDYLVL SURJUDP√ï √∫|\OH ROPD O√ïG√ïU $PHOL\DW VRQUDV√ï LON 
J¬ÅQGH\DS√ïODFDNLGDPHV√ïY√ïWHGDYLVL\XNDU√ïGDNLQLQDPDGGHVLD\Q√ïG√ïU %XV√ïY√ï\DD\U√ïFD 
drena MYHDVSLUDV\RQ\ROX\ODND\EHGLOHQV√ïY√ïYHVSHVLILNHOHNWUROLWOH UHNOHQPHOLGLU+DVWD 
\HWHUOL V√ïY√ï DOG√ï√∑√ï KDOGH SRVWRSHUDWLI VX YH HOHNWUROLW UHW DQVL\RQX ROLJ¬ÅUL\H \RO DoDELOLU 
+DVWD\√ïV√ïY√ï\ODID]OD\¬ÅNOHPHPHNLoLQKHUJ¬ÅQWDUWDUDNV√ïY√ïGHQJHVLNRQWU RO edilmelidir). 
2. 1RUPDOKRPHRVWDWLNPHNDQL]PDODU√ïQLOHULGHUHFHGHER]XOGX√∑XNRPSOLNHL\ LOH√∫PHG|QHPL 
$FLORODUDNE¬Å\¬ÅNDPHOL\DWJHoLUPL√∫YHDPHOL\DWWDQ|QFHNDOS -GDPDUL√∫OHYOHULQRUPDORODQ 
KDVWDODUGD DPHOL\DW VRQUDV√ï VX YH WX] UHWDQVL\RQX QHGHQL\OH KDVW DQ√ïQ ID]OD V√ïY√ï\OD 
y√ºklenmemesi i√ßin, ilk g√ºn %0.2 sodyum klor√ºr i√ßinde dekstroz √ß√∂zeltisi nden 1.5 litre 
X\JXODQ√ïU $\U√ïFD DPHOL\DW |QFHVL YH VRQUDV√ïQGD PLGH -EDUVDN VLVWHPLQGHQ RODQ V√ïY√ï 
ND\√ïSODU√ïX\JXQo|]HOWLOHUOHNDU√∫√ïODQ√ïU+DVWDQ√ïQLGUDUPLNWDU√ï \HWHUOLG¬Å]H\OHUHXOD√∫W√ïNWDQ 
VRQUDLGDPHV√ïY√ïWHGDYLVLQGHLGDPHo|]HOWLOHULNXOODQ√ïO√ïU 
$PHOL\DWWDQVRQUDNLLNLQFLJ¬ÅQGHKDVWDD√∑√ï]GDQV√ïY√ïDODPD\DFDNGXU XPGD\VDSDUHQWHUDO 
V√ïY√ïYHHOHNWUROLWWHGDYLVLQHGHYDPHGLOLU9¬ÅFXW\¬Å]H\LQLQPHWUHND UHVLED√∫√ïQDYHULOHQ 
litre idam HHOHNWUROLWo|]HOWLVLoR√∑XQOXNODV√ïY√ï -HOHNWUROLWDo√ï√∑√ïQ√ïNDSDPD\D\HWHUOLGLU 
3URWHLQNDWDEROL]PDV√ïQ√ï|QOHPHNDPDF√ï\ODKLSHUWRQLNGHNVWUR]o|]HOWLO HULQGHQELUPLNWDU 
NDORUL VD√∑ODQDELOLU 'RNX WDPLULQGH JHUHNOL DPLQRDVLWOHU LVH  DPLQRDVLW NRPELQDV\RQODU√ï 
LoHUHQo|]HOWLOHUOHNDU√∫√ïODQ√ïU 
$FLORODUDNE¬Å\¬ÅNDPHOL\DWJHoLUPL√∫YHDPHOL\DWWDQ|QFHNDOS -GDPDUL√∫OHYOHULER]XNRODQ 
KDVWDODUGDKHUKDVWDELUH\VHORODUDNNRQXQXQX]PDQ√ïKHNLPOHULQGHQHWLP LQGHL]OHQHUHN 
gereksiz metabolik komplikasyonlar √∂nlenmelidir.11/14 5.2 Farmakokinetik √∂zellikler 
Genel √∂zellikler 
LAFLEKS 1/3 LAUDEKS %3.33 DEKSTROZ - % 0.3 SODYUM KLOR√úR dg=(/7√∏6√∏ 
IDUPDNRNLQHWLN|]HOOLNOHULELOH√∫HQOHULQLQGHNVWUR]VRG\XPYHNORU¬ÅU|]HOOLNOH ULQGHQROX√∫XU 
Emilim: 
√∏QWUDYHQ|] \ROGDQ X\JXODQDQ ila√ßlar i√ßindeki etkin maddeler uygulamadan hemen sonra 
PDNVLPXPSOD]PDNRQVDQWUDV\RQODU√ïQDXOD√∫√ïU 
'D√∑√ïO√ïP 
*OXNR] VDDWWH  JNJ
D NDGDU RODQ GR]ODUGD JOXNR]¬ÅUL\H \RO DoPDNV√ï]√ï Q X\JXODQDELOLU (Q 
\¬ÅNVHNLQI¬Å]\RQK√ï]√ïRODQVDDWWHJNJK√ï]√ïQGDX\JXODQDQJOXNR]XQ\DNOD √∫√ïN
LY¬ÅFXWWD 
NDO√ïU 
6RG\XPGD√∑√ïO√ïP√ïGRNXODUDJ|UHGH√∑L√∫LUNDVNDUDFL√∑HUE|EUHNN√ïN√ïUGDNYH GHULGHK√ï]O√ïHULWURVLW 
YHQ|URQODUGD\DYD√∫NHPLNWHLVHoRN\DYD√∫W√ïU 
.ORU¬ÅUHVDVRODUDNK¬ÅFUHG√ï√∫√ïV√ïY√ïODUGDGD√∑√ïO√ïU 
Biyotransformasyon: 
*OXNR]Y¬ÅFXWWDNROD\O√ïNODSLU¬ÅYLNDVLWYH\DODNWLNDVLW\ROXLOHWDP DPHQPHWDEROL]HRODUDNHQHUML 
VD√∑ODUYHE¬Å\¬ÅNRUDQGDNDUERQGLRNVLWLOHVX\DG|Q¬Å√∫¬ÅU 
5DG\RDNWLI RODUDN L√∫DUHWOHQPL√∫ VRG\XP  24 1D HQMHNVL\RQX VRQUDV√ï \DU√ïODQPD |PU¬Å HQMHNWH 
edilen sodyumun %99‚Äôu i√ßin 11- J¬ÅQYHNDODQ¬∂LLoLQELU\√ïOG√ïU 
.ORU¬ÅU VRG\XP PHWDEROL]PDV√ïQ√ï \DN√ïQGDQ L]OHU YH Y¬ÅFXGXQ DVLW -baz dengesinde olan 
GH√∑L√∫LNOLNOHUNORU¬ÅUNRQVDQWUDV\RQXQGDRODQGH√∑L√∫LNOLNOHULOH\DQV√ïW√ïO√ïU 
Eliminasyon:
Glukozun biyotrans IRUPDV\RQXVRQXFXROX√∫DQNDUERQGLRNVLWDNFL√∑HUOHUOHVXLVHHVDVRODU DN 
E|EUHNOHU\ROX\ODD]PLNWDUGDLVHWHUIHoHVYHVROXNKDYDV√ï\ODDW√ïO√ïU 
6RG\XPHVDVRODUDN UHQDO \ROODDW√ïO√ïU IDNDWD\Q√ï ]DPDQGDE¬Å\¬ÅN oR√∑XQOX√∑X UHQDO \ROOD JHUL 
emilir. Az miktarda s RG\XPLVHIHoHVYHWHULOHDW√ïO√ïU 
.ORU¬ÅUPHWDEROLNRODUDNVRG\XPXL]OHQGL√∑LQGHQHVDVRODUDNUHQDO\ ROODD]PLNWDUGDLVHIHoHV 
YHWHULOHDW√ïO√ïU 
'R√∑UXVDOO√ïNGR√∑UXVDOROPD\DQGXUXP 
LAFLEKS 1/3 LAUDEKS %3.33 DEKSTROZ - % 0.3 SODYUM KLOR√úR dg=(/7√∏6√∏¬∂QLQ 
ELOH√∫LPLQGHNLHOHNWUROLWOHUYHJOXNR]Y¬ÅFXWWDHNVLNOLNOHULQLWDPDPO D\DFDNRUDQGD\DQLWHUDS|WLN 
GR]ODUGDYHULOGLNOHULQGHGR√∑UXVDOELUIDUPDNRNLQHWLNGDYUDQ√ï√∫J|VWHULU 12/14 5.3 Klinik √∂ncesi g√ºvenlilik verileri 
d|]HOWLVLQLQELOH√∫HQOHULLQVDQYHKD\YDQSOD]PDV√ïQ√ïQIL]\RORMLNELO H√∫HQOHULROGX√∑XQGDQYHNOLQLN 
X\JXODPD GXUXPXQGD WRNVLN HWNLOHULQ J|U¬ÅOPHVL EHNOHQPHGL√∑LQGHQ NDUVLQRMHQ PXW DMHQ 
SRWDQVL\HOL LOH IHUWLOLWH ¬Å]HULQGHNL HWNLOHULQL GH√∑HUOHQGLUPHN DPDF√ï\OD LAFLEKS 1/3 
LAUDEKS %3.33 DEKSTROZ - % 0.3 SODYUM KLOR√úR dg=(/7√∏6√∏ LOH oDO√ï√∫PDODU 
\DS√ïOPDP√ï√∫W√ïU 
d|]HOWLLoLQHNDW√ïODQLODoODU√ïQHPQL\HWLD\U√ïRODUDNGLNNDWHDO√ïQPD O√ïG√ïU 
)$50$6g7√∏.g=(//√∏./(5 
<DUG√ïPF√ïPDGGHOHULQOLVWHVL 
Enjeksiyonluk su 
6.2. Ge√ßimsizlikler 
d|]HOWL\H HNOHQHFHN LODF√ïQ JHoLPOLOL√∑L |QFHGHQ GH√∑HUOHQGLULO PHOLGLU *HoLPOLOLN YHULOHULQLQ 
EXOXQPDPDV√ïGXUXPODU√ïQGDo|]HOWLKHUKDQJLELULODoLOHNDU√ï√∫W√ïU√ïOPDPDO√ï G√ïU 
d|]HOWLQLQS+¬∂V√ï -DUDV√ïQGDG√ïUd|]HOWL\HLODoHNOHPHGHQ|QFH LAFLEKS 1/3 LAUDEKS 
%3.33 DEKSTROZ - % 0.3 SODYUM KLOR√úR dg=(/7√∏6√∏¬∂QLQS+¬∂V√ïRODQ -DUDV√ïQGD 
VXGD o|]¬ÅQHELOLU YH VWDELO ROGX√∑X GR√∑UXODQPDO√ïG√ïU LAFLEKS 1/3 LAUDEKS %3.33 
DEKSTROZ - % 0.3 SODYUM KLOR√úR dg=(/7√∏6√∏ LOHJHoLPVL]LODoODUGDQED]√ïODU√ï 
‚Ä¢ Ampisilin sodyum 
‚Ä¢ Mitomisin 
‚Ä¢ Amfoterisin B 
‚Ä¢ Eritromisin laktobinat 
*HoLPVL]ROGX√∑XELOLQHQLODoODUHNOHQPHPHOLGLU 
6.3. Raf √∂mr√º 
24 ay. 
6.4. Saklamaya y√∂nelik √∂zel tedbirler 
¬É&¬∂QLQDOW√ïQGDNLRGDV√ïFDNO√ï√∑√ïQGDGR√∑UXGDQ√ï√∫√ïNDOPD\DQELU\HUGHVDNOD\√ïQ√ï]  13/14 $PEDODM√ïQQLWHOL√∑LYHLoHUL√∑L 
100, 150, 250, 500 ml ve 1000 ml‚Äôlik PP (Polipropilen) torbalarda 
hU¬ÅQ¬ÅQVHWOLYHVHWVL]ROPDN¬Å]HUHLNLIRUPXEXOXQPDNWDG√ïU 
%H√∫HULW√ïEEL¬ÅU¬ÅQGHQDUWDNDODQPDGGHOHULQLPKDV√ïYHGL√∑HU|]HO|QOHPO HU 
.XOODQ√ïP|QFHVLo|]HOWLNRQWUROHGLOPHOLGLU 
8\JXODPDVWHULOVHWOHUOHLQWUDYHQ|]\ROGDQ\DS√ïO√ïU 
<DOQ√ï]FDEHUUDNSDUWLN¬ÅOV¬Å]YHDPEDODME¬ÅW¬ÅQO¬Å√∑¬ÅER]XOPDP√ï√∫¬ÅU¬ÅQOHU NXOODQ√ïOPDO√ïG√ïU 
8\JXODPDVHWL¬ÅU¬ÅQHLOL√∫WLULOGLNWHQVRQUDX\JXODPD\DHQN√ïVDV¬ÅUHGHED√∫ODQP DO√ïG√ïU 
7RUEDGDNLUH]LG¬ÅHOKDYD\DED√∑O√ïRODUDNPH\GDQDJHOHELOHFHNELUKDYD HPEROLVLQL|QOHPHNLoLQ 
ED√∫NDLQI¬Å]\RQV√ïY√ïODU√ï\ODVHULED√∑ODQW√ï\DS√ïOPDPDO√ïG√ïU 
d|]HOWLVWHULOX\JXODPDVHWLDUDF√ïO√ï√∑√ï\ODDVHSWLNWHNQL NNXOODQDUDNX\JXODQPDO√ïG√ïU6LVWHPH hava 
JLUPHPHVLLoLQX\JXODPDVHWLQGHQNXOODQ√ïP|QFHVLV√ïY√ïJHoLULOPHOLGLU 
(N LODoODU DVHSWLN NR√∫XOODUGD HQMHNVL\RQ XFXQGDQ ELU L√∑QH \DUG√ïP√ï LOH LQI¬Å]\RQ |QFHVL YH 
V√ïUDV√ïQGD NDW√ïODELOLU 2OX√∫DQ VRQ ¬ÅU¬ÅQ¬ÅQ L]RWRQLWHVL SDUHQWHUDO X\JXODPD  \DS√ïOPDGDQ |QFH 
EHOLUOHQPL√∫ROPDO√ïG√ïU 
+DVWD\DX\JXODPDGDQ|QFHHNOHQPL√∫LODF√ïQo|]HOWL\OHW¬ÅP¬Å\OHND U√ï√∫P√ï√∫ROPDV√ïJHUHNOLGLU(N 
LODoLoHUHQo|]HOWLOHULODoHNOHQPHVLQGHQKHPHQVRQUDNXOODQ√ïOPD O√ïG√ïUGDKDVRQUDNXOODQ√ïOPDN 
¬Å]HUHVDNODQPDPDO√ïG√ïU 
√á√∂zeltiye ek ila√ß NDW√ïOPDV√ï \DGD \DQO√ï√∫X\JXODPDWHNQL√∑L¬ÅU¬ÅQHSLURMHQNRQWDPLQDV\RQXQ D 
ED√∑O√ï DWH√∫ UHDNVL\RQXQD QHGHQ RODELOLU $GYHUV UHDNVL\RQ J|U¬ÅOPHVL GXU XPXQGD LQI¬Å]\RQD 
hemen son verilmelidir. 
7HNNXOODQ√ïPO√ïNW√ïU .√ïVPHQNXOODQ√ïOP√ï√∫o|]HOWLOHUVDNODQPDPDO√ïG√ïU 
.√ïVPHQNXOODQ√ïOP√ï√∫WRUEDODU\HQLGHQKDVWD\DX\JXODQDQVLVWHPOHUHED√∑ODQP DPDO√ïG√ïU 
A√ßmak i√ßin: 
1. '√ï√∫ DPEDODM√ïQ VD√∑ODPO√ï√∑√ïQ√ï YH V√ï]√ïQW√ï ROXS ROPDG√ï√∑√ïQ√ï NRQWURO H GLQL] DPEDODM KDVDU 
J|UP¬Å√∫VHNXOODQPD\√ïQ√ï] 
2. .RUX\XFXG√ï√∫DPEDODM√ï\√ïUWDUDNDo√ïQ√ï] 
3. Koruyucu ambalaj i oLQGHNLWRUEDQ√ïQVD√∑ODPROXSROPDG√ï√∑√ïQ√ïV√ïNDUDNNRQWUROHGLQL]7RUED 
LoLQGHNLo|]HOWLQLQEHUUDNO√ï√∑√ïQ√ïYHLoLQGH\DEDQF√ïPDGGHLoHUPHGL√∑LQLNRQWURO HGLQL] 
8\JXODPDKD]√ïUO√ïNODU√ï 
1. 7RUED\√ïDV√ïQ√ï] 
2. 8\JXODPDXFXQGDNLNRUX\XFXNDSD√∑√ïo√ïNDU√ïQ√ï] 
3. Uygulama setini QVSD\N√ïQ√ïX\JXODPDXFXQDV√ïN√ïFDEDW√ïU√ïQ√ï] 
4. d|]HOWLQLQKDVWD\DX\JXODQPDV√ïLoLQVHWLQNXOODQ√ïPWDOLPDW√ïQDX\XOPDO√ï G√ïU 14/14 Ek ila√ß ekleme: 
Dikkat 7¬ÅPSDUHQWHUDOo|]HOWLOHUGHROGX√∑XJLEL¬ÅU¬ÅQHHNOHQHFHNW¬ÅPPDGGHO HU¬ÅU¬ÅQOHJHoLPOL 
ROPDO√ïG√ïUhU¬ÅQHHNOHPH\DS√ïODFDNVDKDVWD\DX\JXODPDGDQ|QFHVRQ NDU√ï√∫√ïP√ïQGDJHoLPOLOLN 
kontrol edilmelidir. 
Uygulama √∂ncesi ila√ß ekleme: 
1. 7RUEDQ√ïQX\JXODPDXFXGH]HQIHNWHHGLOLU 
2. Eklenecek ila√ß 19- JDXJHNDO√ïQO√ï√∑√ïQGDNLELUL√∑QHVLRODQHQMHNW|UOHWRUEDLoLQHHNOHQLU 
3. d|]HOWLYHLoLQHHNOHQHQLODoL\LFHNDU√ï√∫W√ïU√ïO√ïU3RWDV\XP NORU¬ÅUJLEL\R√∑XQLODoODUGDWRUEDQ√ïQ 
X\JXODPD o√ïN√ïV√ïQD \XNDU√ï SR]LV\RQGD\NHQ KDILIoH YXUXODUDN LODF√ïQ o|]HOWL\OH W¬ÅP¬Å\OH 
NDU√ï√∫PDV√ïVD√∑ODQ√ïU 
Dikkat √∏oLQHHNLODoX\JXODQP√ï√∫WRUEDODUVDNODQPDPDO√ïG√ïU 
8\JXODPDV√ïUDV√ïQGDLODoHNOHPH 
1. 6HWLQNOHPSLNDSDW√ïO√ïU 
2. √∏ODoX\JXODPDXFXGH]HQIHNWHHGLOLU 
3. Eklenecek ila√ß 19- JDXJHNDO√ïQO√ï√∑√ïQGDNLELUL√∑QHVLRODQHQMHNW|UOHLODoX\JXODPDXF XQGDQ 
X\JXODQ√ïU 
4. d|]HOWLDVN√ïV√ïQGDQo√ïNDU√ïO√ïUYHWHUVoHYULOLU 
5. Bu pozis \RQGD\NHQ WRUEDQ√ïQ X\JXODPD o√ïN√ï√∫√ï YH HQMHNVL\RQ JLUL√∫LQH KDILIoH YXUXOD UDN 
o|]HOWLYHHNLODF√ïQNDU√ï√∫PDV√ïVD√∑ODQ√ïU 
6. 7RUED\√ïHVNLNRQXPXQDJHWLUHUHNNOHPSDo√ïO√ïUYHX\JXODPD\DGHYDPHGLOLU 
58+6$76$+√∏%√∏ 
$G√ï 063KDUPD√∏ODo6DQYH7LF$√π 
Adres : UOD√∫26%0DK'&DG(UJHQH26%1R(UJHQH7HNLUGD√∑ 
8.RUHSAT NUMARASI 
250/87 
√∏/.58+6$77$5√∏+√∏58+6$7<(1√∏/(0(7$5√∏+√∏ 
√∏ONUXKVDWWDULKL 
Ruhsat yenileme tarihi: 
.h%¬∂h1<(1√∏/(10(7$5√∏+√∏ 
13 Nisan 2017 13 Nisan 2017 